Arbor Biotechnologies

Arbor Biotechnologies

Latest funding
$215,000,000
Venture capital (Series B) - 2021
ARCH Venture Partners Vertex Tao Capital Partners +17
Team Size
1–10
Employees
$215,000,000 Venture capital (Series B)
MedCity News

CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies